Search & Analyze
Popular Searches
Valiant Laboratories Ltd.
Healthcare₹60.173.73%
24 Jul, 4:01 PM
CMP₹60.17
Mkt Cap₹339 Cr
P/E0.00
P/B1.09
ROE-0.93%
52W High₹99.31
52W Low₹50.00
Customise metrics bar
Stock DNA
Key Ratios
P/B Ratio
1.09
EV/EBITDA
43.32
Price/Sales
1.43
Dividend Yield (%)
0.00
EPS (TTM ₹)
-0.60
Book Value (₹)
57.24
ROE (%)
-0.93
ROCE (%)
-0.40
ROA (%)
-0.59
EBITDA Margin (%)
-3.52
Net Profit Margin (%)
-1.65
Debt/Equity
0.52
Current Ratio
3.23
Interest Coverage
-7.63
Asset Turnover
0.36
Working Capital/Sales
1.00
Core EBITDA Growth (%)
-40.72
P&L
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Gross Sales | 33390.95 | 18205.72 | 13338.2 |
| Net Sales | 33390.95 | 18205.72 | 13338.2 |
| Total Income | 33879.63 | 19174.04 | 13883.15 |
| Total Expenditure | 29884.31 | 19046.63 | 13807.62 |
| Operating Profit | 3995.32 | 127.41 | 75.53 |
| Depreciation | 156.31 | 196.58 | 209.26 |
| Exceptional Items | — | — | — |
| Profit Before Tax | 3813.64 | -76.95 | -151.26 |
| Tax | 913.81 | -108.91 | 68.86 |
| Profit After Tax (PAT) | 2899.83 | 31.96 | -220.12 |
| EPS (₹) | 8.91 | 0.13 | -0.51 |
| Dividend Payout % | — | — | — |
Balance Sheet
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Share Capital | 3256 | 4345 | 4345 |
| Reserves | 6793.08 | 19341.12 | 19086.01 |
| Shareholders Funds | 10049.08 | 23686.12 | 23431.01 |
| Total Debt | 5940.02 | 7605.05 | 12120.46 |
| Total Liabilities | 21296.55 | 34268.73 | 40085.75 |
| Total Assets | 21296.55 | 34268.73 | 40085.75 |
| Book Value / Share | 30.8633 | 54.5135 | 53.9264 |
| Assets | 21296.55 | 34268.73 | 40085.75 |
Cash Flows
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Operating Activities | 5605.11 | 188.54 | 131.32 |
| Investing Activities | -5516.82 | -14387.68 | -5276.77 |
| Financing Activities | -93.39 | 15244.8 | 4465.28 |
| Net Cash Flow | -5.1 | 1045.66 | -680.17 |
VALIANTLAB
₹60.17
-3.73%